Registro completo |
Provedor de dados: |
BJMBR
|
País: |
Brazil
|
Título: |
In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy
|
Autores: |
Souza-Fagundes,E.M.
Cota,B.B.
Rosa,L.H.
Romanha,A.J.
Corrêa-Oliveira,R.
Rosa,C.A.
Zani,C.L.
Teixeira-Carvalho,A.
Martins-Filho,O.A.
|
Data: |
2010-11-01
|
Ano: |
2010
|
Palavras-chave: |
Chagas disease
Leishmaniasis
Chemotherapy
Immunomodulation
Hypnophilin
Lentinus strigosus
|
Resumo: |
Hypnophilin and panepoxydone, terpenoids isolated from Lentinus strigosus, have significant inhibitory activity onTrypanosoma cruzi trypanothione reductase (TR). Although they have similar TR inhibitory activity at 10 μg/mL (40.3 μM and 47.6 μM for hypnophilin and panepoxydone, respectively; ~100%), hypnophilin has a slightly greater inhibitory activity (~71%) on T. cruzi amastigote (AMA) growth in vitro as well as on in vitro phytohemagglutinin (PHA)-induced peripheral blood mononuclear (PBMC) proliferation (~70%) compared to panepoxydone (69% AMA inhibition and 91% PBMC inhibition). Hypnophilin and panepoxydone at 1.25 μg/mL had 67% inhibitory activity onLeishmania (Leishmania) amazonensis amastigote-like (AMA-like) growth in vitro. The panepoxydone activity was accompanied by a significant inhibitory effect on PHA-induced PBMC proliferation, suggesting a cytotoxic action. Moreover, incubation of human PBMC with panepoxydone reduced the percentage of CD16+ and CD14+ cells and down-regulated CD19+, CD4+ and CD8+ cells, while hypnophilin did not alter any of the phenotypes analyzed. These data indicate that hypnophilin may be considered to be a prototype for the design of drugs for the chemotherapy of diseases caused by Trypanosomatidae.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001100007
|
Editor: |
Associação Brasileira de Divulgação Científica
|
Relação: |
10.1590/S0100-879X2010007500108
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Medical and Biological Research v.43 n.11 2010
|
Direitos: |
info:eu-repo/semantics/openAccess
|